Advertisement

Topics

Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation

02:00 EDT 25 Mar 2013 |

Dear Investor, Please find attached a press release by Chugai. Do not hesitate to contact us for any further questions.

Original Article: Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation

NEXT ARTICLE

More From BioPortfolio on "Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation"

Advertisement
Quick Search
Advertisement
Advertisement